| UniProt ID | ZN180_HUMAN | |
|---|---|---|
| UniProt AC | Q9UJW8 | |
| Protein Name | Zinc finger protein 180 | |
| Gene Name | ZNF180 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 692 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in transcriptional regulation.. | |
| Protein Sequence | MRACAGSTREAGSGAQDLSTLLCLEESMEEQDEKPPEPPKACAQDSFLPQEIIIKVEGEDTGSLTIPSQEGVNFKIVTVDFTREEQGTWNPAQRTLDRDVILENHRDLVSWDLATAVGKKDSTSKQRIFDEEPANGVKIERFTRDDPWLSSCEEVDDCKDQLEKQQEKQEILLQEVAFTQRKAVIHERVCKSDETGEKSGLNSSLFSSPVIPIRNHFHKHVSHAKKWHLNAAVNSHQKINENETLYENNECGKPPQSIHLIQFTRTQTKDKCYGFSDRIQSFCHGTPLHIHEKIHGGGKTFDFKECGQVLNPKISHNEQQRIPFEESQYKCSETSHSSSLTQNMRNNSEEKPFECNQCGKSFSWSSHLVAHQRTHTGEKPYECSECGKSFSRSSHLVSHQRTHTGEKPYRCNQCGKSFSQSYVLVVHQRTHTGEKPYECNQCGKSFRQSYKLIAHQRTHTGEKPYECNQCGKSFIQSYKLIAHQRIHTGEKPYECNQCGKSFSQSYKLVAHQRTHTGEKPFECNQCGKSFSWSSQLVAHQRTHTGEKPYECSECGKSFNRSSHLVMHQRIHTGEKPYECNQCGKSFSQSYVLVVHQRTHTGEKPYECSQCGKSFRQSSCLTQHQRTHTGEKPFECNQCGKTFSLSARLIVHQRTHTGEKPFTCIQCGKAFINSYKLIRHQATHTEEKLYECN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 68 | Phosphorylation | TGSLTIPSQEGVNFK CCCEEEECCCCCCEE | 36.69 | 17525332 | |
| 120 | Ubiquitination | LATAVGKKDSTSKQR HHHHHCCCCCCCCCC | 51.48 | - | |
| 138 | Sumoylation | EEPANGVKIERFTRD CCCCCCCEEEEECCC | 40.00 | - | |
| 138 | Sumoylation | EEPANGVKIERFTRD CCCCCCCEEEEECCC | 40.00 | 28112733 | |
| 159 | Sumoylation | CEEVDDCKDQLEKQQ CCCHHHHHHHHHHHH | 56.34 | 28112733 | |
| 168 | Sumoylation | QLEKQQEKQEILLQE HHHHHHHHHHHHHHH | 49.22 | - | |
| 168 | Sumoylation | QLEKQQEKQEILLQE HHHHHHHHHHHHHHH | 49.22 | 28112733 | |
| 191 | Sumoylation | VIHERVCKSDETGEK HHEEEEECCCCCCCC | 59.07 | 28112733 | |
| 198 | Ubiquitination | KSDETGEKSGLNSSL CCCCCCCCCCCCHHH | 51.69 | - | |
| 198 | Sumoylation | KSDETGEKSGLNSSL CCCCCCCCCCCCHHH | 51.69 | 28112733 | |
| 199 | Phosphorylation | SDETGEKSGLNSSLF CCCCCCCCCCCHHHC | 44.18 | - | |
| 226 | Sumoylation | KHVSHAKKWHLNAAV HHHHHHHHHHHHHHH | 40.40 | - | |
| 226 | Sumoylation | KHVSHAKKWHLNAAV HHHHHHHHHHHHHHH | 40.40 | 28112733 | |
| 286 | Phosphorylation | IQSFCHGTPLHIHEK HHHHCCCCCEEECEE | 10.06 | 28555341 | |
| 293 | Ubiquitination | TPLHIHEKIHGGGKT CCEEECEEECCCCCE | 26.32 | - | |
| 299 | Sumoylation | EKIHGGGKTFDFKEC EEECCCCCEECHHHH | 49.66 | - | |
| 299 | Sumoylation | EKIHGGGKTFDFKEC EEECCCCCEECHHHH | 49.66 | - | |
| 299 | Ubiquitination | EKIHGGGKTFDFKEC EEECCCCCEECHHHH | 49.66 | - | |
| 304 | Sumoylation | GGKTFDFKECGQVLN CCCEECHHHHCCCCC | 54.67 | 28112733 | |
| 304 | Sumoylation | GGKTFDFKECGQVLN CCCEECHHHHCCCCC | 54.67 | - | |
| 313 | Ubiquitination | CGQVLNPKISHNEQQ HCCCCCCCCCCCCCC | 56.63 | - | |
| 313 | Sumoylation | CGQVLNPKISHNEQQ HCCCCCCCCCCCCCC | 56.63 | 28112733 | |
| 330 | Sumoylation | PFEESQYKCSETSHS CCCHHHHHHCCCCCC | 24.52 | - | |
| 330 | Ubiquitination | PFEESQYKCSETSHS CCCHHHHHHCCCCCC | 24.52 | - | |
| 330 | Sumoylation | PFEESQYKCSETSHS CCCHHHHHHCCCCCC | 24.52 | 28112733 | |
| 334 | Phosphorylation | SQYKCSETSHSSSLT HHHHHCCCCCCCHHH | 18.55 | 19690332 | |
| 335 | Phosphorylation | QYKCSETSHSSSLTQ HHHHCCCCCCCHHHH | 19.81 | 19690332 | |
| 338 | Phosphorylation | CSETSHSSSLTQNMR HCCCCCCCHHHHHHC | 24.76 | 19690332 | |
| 374 | Phosphorylation | HLVAHQRTHTGEKPY CCEEECCCCCCCCCE | 19.74 | - | |
| 376 | Phosphorylation | VAHQRTHTGEKPYEC EEECCCCCCCCCEEC | 46.56 | - | |
| 379 | Ubiquitination | QRTHTGEKPYECSEC CCCCCCCCCEECCCC | 55.00 | - | |
| 391 | Phosphorylation | SECGKSFSRSSHLVS CCCCCCCCCCCCCCC | 38.04 | 17081983 | |
| 402 | Phosphorylation | HLVSHQRTHTGEKPY CCCCCCCCCCCCCCE | 19.74 | - | |
| 404 | Phosphorylation | VSHQRTHTGEKPYRC CCCCCCCCCCCCEEC | 46.56 | 24719451 | |
| 407 | Acetylation | QRTHTGEKPYRCNQC CCCCCCCCCEECCCC | 49.01 | 30593607 | |
| 430 | Phosphorylation | VLVVHQRTHTGEKPY EEEEEECCCCCCCCC | 19.74 | - | |
| 432 | Phosphorylation | VVHQRTHTGEKPYEC EEEECCCCCCCCCCC | 46.56 | - | |
| 435 | Ubiquitination | QRTHTGEKPYECNQC ECCCCCCCCCCCCCC | 55.00 | - | |
| 435 | Sumoylation | QRTHTGEKPYECNQC ECCCCCCCCCCCCCC | 55.00 | - | |
| 435 | Sumoylation | QRTHTGEKPYECNQC ECCCCCCCCCCCCCC | 55.00 | - | |
| 451 | Sumoylation | KSFRQSYKLIAHQRT HHHHHHHHHHEECCC | 38.37 | - | |
| 451 | Sumoylation | KSFRQSYKLIAHQRT HHHHHHHHHHEECCC | 38.37 | - | |
| 458 | Phosphorylation | KLIAHQRTHTGEKPY HHHEECCCCCCCCCC | 19.74 | - | |
| 460 | Phosphorylation | IAHQRTHTGEKPYEC HEECCCCCCCCCCCC | 46.56 | - | |
| 463 | Ubiquitination | QRTHTGEKPYECNQC CCCCCCCCCCCCCCC | 55.00 | - | |
| 463 | Sumoylation | QRTHTGEKPYECNQC CCCCCCCCCCCCCCC | 55.00 | - | |
| 463 | Sumoylation | QRTHTGEKPYECNQC CCCCCCCCCCCCCCC | 55.00 | - | |
| 479 | Sumoylation | KSFIQSYKLIAHQRI HHHHHHHHHHEECEE | 38.37 | - | |
| 479 | Sumoylation | KSFIQSYKLIAHQRI HHHHHHHHHHEECEE | 38.37 | - | |
| 488 | Phosphorylation | IAHQRIHTGEKPYEC HEECEECCCCCCCCC | 44.67 | 27282143 | |
| 491 | Ubiquitination | QRIHTGEKPYECNQC CEECCCCCCCCCCCC | 55.00 | - | |
| 514 | Phosphorylation | KLVAHQRTHTGEKPF CEEEECCCCCCCCCE | 19.74 | - | |
| 516 | Phosphorylation | VAHQRTHTGEKPFEC EEECCCCCCCCCEEC | 46.56 | - | |
| 519 | Ubiquitination | QRTHTGEKPFECNQC CCCCCCCCCEECCCC | 57.25 | - | |
| 542 | Phosphorylation | QLVAHQRTHTGEKPY HHHEECCCCCCCCCC | 19.74 | - | |
| 544 | Phosphorylation | VAHQRTHTGEKPYEC HEECCCCCCCCCCCC | 46.56 | - | |
| 547 | Ubiquitination | QRTHTGEKPYECSEC CCCCCCCCCCCCCCC | 55.00 | - | |
| 572 | Phosphorylation | VMHQRIHTGEKPYEC EEECEEECCCCCCCC | 44.67 | 27282143 | |
| 575 | Ubiquitination | QRIHTGEKPYECNQC CEEECCCCCCCCCCC | 55.00 | - | |
| 598 | Phosphorylation | VLVVHQRTHTGEKPY EEEEEECCCCCCCCE | 19.74 | - | |
| 600 | Phosphorylation | VVHQRTHTGEKPYEC EEEECCCCCCCCEEH | 46.56 | - | |
| 621 | Phosphorylation | FRQSSCLTQHQRTHT HHHHHCCCCCCCCCC | 28.47 | - | |
| 626 | Phosphorylation | CLTQHQRTHTGEKPF CCCCCCCCCCCCCCE | 19.74 | - | |
| 628 | Phosphorylation | TQHQRTHTGEKPFEC CCCCCCCCCCCCEEC | 46.56 | - | |
| 631 | Ubiquitination | QRTHTGEKPFECNQC CCCCCCCCCEECCCC | 57.25 | - | |
| 641 | Phosphorylation | ECNQCGKTFSLSARL ECCCCCCEEEEEEEE | 12.07 | 26552605 | |
| 643 | Phosphorylation | NQCGKTFSLSARLIV CCCCCEEEEEEEEEE | 27.01 | 19664995 | |
| 645 | Phosphorylation | CGKTFSLSARLIVHQ CCCEEEEEEEEEEEE | 15.33 | 26552605 | |
| 654 | Phosphorylation | RLIVHQRTHTGEKPF EEEEEECCCCCCCCE | 19.74 | - | |
| 656 | Phosphorylation | IVHQRTHTGEKPFTC EEEECCCCCCCCEEE | 46.56 | - | |
| 675 | Sumoylation | KAFINSYKLIRHQAT CHHHHHHHHHHHCCC | 36.94 | - | |
| 675 | Sumoylation | KAFINSYKLIRHQAT CHHHHHHHHHHHCCC | 36.94 | - | |
| 689 | Phosphorylation | THTEEKLYECN---- CCCHHHHHCCC---- | 29.51 | 27642862 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN180_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN180_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN180_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NDEL1_HUMAN | NDEL1 | physical | 25416956 | |
| KR107_HUMAN | KRTAP10-7 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY. | |